Disease Models

Our comprehensive portfolio of disease models spans multiple therapeutic areas, providing reliable preclinical platforms to study disease mechanisms and accelerate the development of innovative therapies.

Inquiry
  • Overview
  • Disease Models
  • FAQs

Creative Bioarray offers a comprehensive portfolio of well-established and customized disease models to support preclinical efficacy evaluation of your therapeutic candidates. With proven expertise in disease models, our scientific team collaborates closely with clients to recommend the most clinically relevant in vivo models tailored to their target indications. From autoimmune and metabolic disorders to oncology and neurological diseases, we provide robust, translational models that help de-risk your pipeline and accelerate drug development.

Whether you need standardized study protocols or fully customized model development, Creative Bioarray is your reliable partner for high-quality, reproducible efficacy data. Explore our therapeutic areas below or contact us to discuss a tailored study plan and receive a quote.

Our Disease Model Platforms

120+

Validated Animal Models

17

Therapeutics Areas

19

Years Experience

Oncology Models

Comprehensive oncology models, from CDX to PDX, enabling translational cancer research and novel therapy development.

Ocular Disease Models

Ocular models address inflammatory, vascular, and degenerative eye disorders, providing platforms for vision-related therapeutic studies.

  • Inflammatory Disorders
  • Eye Irritation
  • Retinopathy Of Prematurity
  • Stromal Ulceration
  • Corneal Graft
  • Infectious Keratitis
  • Diabetic Retinopathy
  • Glaucoma Model
  • Dry Eye Model

Read More

Metabolic Disease Models

Translational platforms that reproduce key metabolic disorders, enabling early assessment of therapeutic potential.

Liver Disease Models

Comprehensive liver models spanning acute, chronic, and metabolic conditions to support drug evaluation and safety studies.

Read More

Digestive Disease Models

GI models simulating NEC, IBS, gastric ulcers, pancreatitis, and IBD to facilitate translational research in digestive health.

Pain Models

Versatile pain models that reflect multiple pain mechanisms to advance analgesic research and therapy development.

Skin Disease Models

Comprehensive skin models covering hair growth, wound healing, acne, and photoaging to advance dermatological research and therapy innovation.

Read More

Orthopedic Disease Models

Validated bone and joint disease models that reproduce osteoarthritis and osteoporosis for musculoskeletal drug discovery.

Infectious Disease Models

Versatile infection models for bacteria, viruses, and fungi, enabling evaluation of host-pathogen interactions and anti-infective therapies.

  • Bacteria
  • Virus
  • Fungi

Read More

Rare Disease Models

Specialized models for rare genetic and autoimmune disorders provide valuable systems to explore disease etiology and novel treatment approaches.

Reproductive Disease Models

Models replicating reproductive disorders such as PCOS, endometriosis, and erectile dysfunction to support therapeutic development in reproductive health.

Otology Disease Models

Preclinical hearing loss models that provide valuable systems for studying auditory disorders and testing novel treatments.

Read More

Together with our well-established rodent platforms, we offer a comprehensive suite of NHP services to support preclinical research across multiple stages of drug development. These advanced NHP capabilities provide critical translational insights that go beyond what rodent studies can offer, particularly for biologics, vaccines, and cell and gene therapies. In addition to our NHP services, we also provide a range of NHP-related products to support your research needs. For a detailed overview of our NHP capabilities, please visit our dedicated NHP section.

FAQs

1. Can we customize disease models to fit our specific research needs?

Yes, we offer customization options for our disease models. Please reach out to our team to discuss your specific requirements and we will work closely with you to develop the most suitable model.

2. What species are included in your animal models?

Our offerings include various species such as mice, rats, rabbits, Guinea pigs, and non-human primates (NHPs), depending on the disease model and the specific requirements of your study.

3. How long do studies with disease models typically take?

The duration of studies varies based on the complexity of the model and the specific objectives of your research. Typically, they can range from a few weeks to several months. We will provide timelines during the project planning phase.

4. What types of outcomes can we measure using your disease models?

Our disease models allow for a wide range of outcome measurements, including pharmacokinetics (PK), pharmacodynamics (PD), efficacy, safety, and histopathological evaluations. Additionally, we provide comprehensive endpoint assessments such as biomarker analysis, imaging, behavioral tests (for CNS models), cytokine profiling, and functional assessments tailored to the specific model in use.

5. What are the costs associated with using your disease models?

Costs depend on the specific model and services required. We strive to provide competitive pricing and will give you a detailed quote based on your project's scope and customizations.

Quotation and Ordering

If the in vivo disease model you're seeking is not listed, or if you have any further questions, please don't hesitate to contact us at . We would be pleased to assist you.

For research use only. Not for any other purpose.

Online Inquiry